PrecisionLife is led by our Co-founder & CEO Dr Steve Gardner, supported by our wider management team, each of whom have significant experience and expertise in their field.
Steve is a serial technology entrepreneur with over 25 years’ experience developing and commercializing ground-breaking data science and informatics in the healthcare, life sciences and agri-food sectors.
Never afraid to innovate, Steve has an established track record in building world-class companies, teams and products working at senior levels in the UK, EU and US for Fortune 500 and start-up companies.
He is a former Global Director of Research Informatics for Astra A/B and has consulted with drug discovery and safety teams in over 20 biopharma companies.
Véronique is a medical expert and strategic thinker with over 30 years’ experience in the pharmaceutical, biotech and digital health sectors.
She is a former Director of Corporate Strategy and Head of Venture Strategy at AstraZeneca, where she was responsible for global corporate venturing activities, including the creation and $40M financing of the company’s first spinout, Albireo Pharma. She has also held posts in clinical research, licensing, M&A, venture capital and the NHS.
This varied experience has given her an in-depth understanding of what is required to translate cutting edge science into commercial reality.
Gert is an entrepreneur with over 20 years of experience of driving new innovations in AI, precision medicine and digital health.
He invented and developed some of the novel AI solutions which are the foundation of PrecisionLife’s core technology. He is the principal inventor on our patents for the PACE technologies and has won a number of major awards for his innovations.
Working with our multi-disciplinary team of scientists, engineers and commercial experts, Gert has also helped solve challenges in clinical genomics and bioinformatics including conducting population scale genomics studies based on multiple combinations of SNPs or other markers.
Mark is the planner and organiser who coordinates the design and delivery of PrecisionLife’s innovative platforms and projects.
He has a long and varied career in bioinformatics in both human and animal disease studies across academia, industry and the clinical sectors. Mark started his career building the informatics group for the MRC’s Mammalian Genetics Unit before moving into the bio-pharmaceutical industry and onto Baylor College of Medicine.
Mark’s career has encompassed the design and development of complex scientific software, clinical lab IT systems, and informatics products and this background is perfectly suited to the challenge of bringing together all of the streams of scientific, technical, and clinical innovation in our platforms.
Simon joined PrecisionLife in September 2020 and leads our healthcare partnering program having spent more than 20 years managing product and business strategy teams for innovative informatics businesses in the healthcare and life science ecosystems.
Before joining the company, Simon was Director of Healthcare at Linguamatics, leading their healthcare business unit for seven years.
Prior to that, he spent five years at InforSense and IDBS leading product marketing efforts and served as Marketing Director of Translational Medicine at IDBS Healthcare.
Maria is a commercially astute, hands-on finance professional with strong business analysis and modelling skills.
As a chartered management accountant, she has held a number of finance leadership positions across large listed companies as well as SMEs and start-ups.
She is responsible for organizing the financial management of the Group, which includes all financial operations, cash management, compliance, tax and statutory reporting.
Maria has experience working within multiple sectors including the publishing, software technology, music media and manufacturing industries.